Laurens J Ceulemans,Dorina Esendagli,Giuseppe Cardillo et al.
Laurens J Ceulemans et al.
Volume reduction is a disease-modifying treatment that aims to reshape the diseased lung towards a more normal total lung capacity by removing severely damaged and overinflated lung parenchyma. It is an effective therapeutic strategy in wel...
Gráinne dAncona,Brian D Kent
Gráinne dAncona
Inhaled therapies, primarily the inhaled corticosteroid (ICS), have been the cornerstone of asthma treatment since the 1960s. They have been shown to reduce symptom burden, morbidity and mortality, and potentially avoid unnecessary and unsc...
Alannah Murray,Laura Piggott,James OHanlon et al.
Alannah Murray et al.
This is the first case report detailing co-infection with both PJP and disseminated histoplasmosis in a patient without HIV infection, and it highlights the immune-suppressive potential of poorly controlled diabetes and liver cirrhosis http...
High-flow nasal cannula is an expensive and clunky placebo: myth or maxim? [0.03%]
高流量鼻导管吸氧是昂贵且笨重的安慰剂:事实还是误解?
Gareth A L Jones,Padmanabhan Ramnarayan
Gareth A L Jones
High-flow nasal cannula (HFNC) is now a commonly used noninvasive method of providing respiratory support to children and young people. Its rapid spread into varied clinical applications has often left assessment of the evidence of its mech...
Advances in tuberculosis biomarkers: unravelling risk factors, active disease and treatment success [0.03%]
结核病生物标志物研究进展:揭示危险因素、活动性感染及治疗效果
Jodie A Schildkraut,Niklas Köhler,Christoph Lange et al.
Jodie A Schildkraut et al.
Tuberculosis (TB) is a major global health threat and demands improved diagnostic and treatment monitoring methods. Conventional diagnostics, such as sputum smear microscopy and culture, are limited by slow results and low sensitivity, part...
Mairi McClean,Traian Constantin Panciu,Christoph Lange et al.
Mairi McClean et al.
The challenges to effective tuberculosis (TB) disease control are considerable, and the current global targets for reductions in disease burden seem unattainable. The combination of complex pathophysiology and technical limitations results ...
Neeraj M Shah,Nicholas Hart,Georgios Kaltsakas
Neeraj M Shah
Weaning from invasive mechanical ventilation is an important part of the management of respiratory failure patients. Patients can be classified into those who wean on the first attempt (simple weaning), those who require up to three attempt...
ERS/ATS Global Lung Function Initiative normal values and classifying severity based on z-scores instead of per cent predicted [0.03%]
ERS/ATS全球肺功能计划正常值及基于Z评分(而非预测百分比)划分疾病严重程度
Rachel Ong-Salvador,Pierantonio Laveneziana,Franciscus de Jongh
Rachel Ong-Salvador
Among the most discussed issues in the field of pulmonary function testing are reference equations and standardised methods of interpreting pulmonary function test (PFT) results. The Global Lung Function Initiative (GLI) task force gathered...
Senani N H Rathnayake,Joana Cruz,Sara Cuevas Ocaña et al.
Senani N H Rathnayake et al.
In this early career forum, the 2023 ECM awardee shares her insights into research, her career path, her personal life and collaborations (@Mkg_Lehmann) https://bit.ly/4f0AiVY. ...
Artificial intelligence in respiratory care: perspectives on critical opportunities and challenges [0.03%]
呼吸护理中的人工智能:抓住机遇和迎接挑战的展望
David Drummond,Ireti Adejumo,Kjeld Hansen et al.
David Drummond et al.
Artificial intelligence (AI) is transforming respiratory healthcare through a wide range of deep learning and generative tools, and is increasingly integrated into both patients' lives and routine respiratory care. The implications of AI in...